Therapy Elmo? Social media manager weighs in on Elmo's inadvertent mental health check

  • 📰 L.A. Times Health
  • ⏱ Reading Time:
  • 26 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 14%
  • Publisher: 59%

Health Health Headlines News

Health Health Latest News,Health Health Headlines

Elmo's 25-year-old Sesame Workshop social media manager was also behind his 2022 feud with Abby's pet rock, Rocco: 'Lightning did strike twice — and then some.'

In its effort to seek comfort from an iconic childhood friend, the Internet almost broke Elmo. The 'Sesame Street' star's viral tweet checking in on everyone this week was written by his 25-year-old social media manager, who inadvertently turned X into a therapist's couch where users opened up to the beloved Muppet — and the Internet — about their internal struggles. For Christina Vittas — the Hoboken, N.J.

This question felt like a natural fit for a loveable, caring friend like Elmo, especially as he learns more and more about his own emotional well-being,' Vittas said Thursday in a statement to The Times. She's grateful that the tweet has 'opened up conversations about the serious mental health crisis in our country and thankful that here at Sesame Workshop, we can support children and families in this moment with our Emotional Wellbeing resources,' she added. 'Elmo did that.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 364. in HEALTH

Health Health Latest News, Health Health Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

First-Ever CRISPR-Based Therapy Approved for Sickle Cell DiseaseU.S. patients with sickle cell disease now have a novel treatment option: the first-ever CRISPR-based therapy.for use in patients age 12 years and older. In addition to offering hope of relief for people with severe forms of the painful blood disorder, the treatment, called Casgevy, is the world’s first to genetically tweak cells using theAnother gene therapy for sickle cell disease, called Lyfgenia and developed by biotech company bluebird bio, based in Somerville, Mass., was also approved December 8. Getting a green light for the first CRISPR-based medicine is exciting, says David Altshuler, chief scientific officer at Boston-based Vertex Pharmaceuticals, which developed the drug in a joint venture with CRISPR Therapeutics, a company in Cambridge, Mass. But the fact that the drug fills an unmet need for underserved patients is “more compelling to me, personally, than the fact that it’s CRISPR.” , most of them Black or Latino, have sickle cell disease. It is caused by a genetic defect in hemoglobin, the oxygen-carrying protein in red blood cells
Source: ScienceNews - 🏆 286. / 63 Read more »